Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

EXPERIMENTAL CONDITION - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:lysergic acid diethylamide
go back to main search page
Accession:XCO:0001490 term browser browse the term
Definition:This is any condition in which the main influencing factor is lysergic acid diethylamide, a semisynthetic derivative of ergot (Claviceps purpurea) that has complex effects on both peripheral and central nervous system serotonergic receptors. Lysergic acid diethylamide is a potent hallucinogen.
Synonyms:exact_synonym: (8R)-9,10-didehydro-N,N-diethyl-6-methylergoline-8-carboxamide;   D-Lsd;   D-Lysergic acid diethylamide;   LAD;   LSD;   LSD-25;   Lysergide
 narrow_synonym: Delysid;   LSD tartrate
 xref: CHEBI:6605;   CID:5761



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 2376
    therapeutic agent 101
      antianxiety agent 0
        lysergic acid diethylamide 0
Path 2
Term Annotations click to browse term
  experimental condition 2376
    chemical 1266
      chemical with specified function 517
        activator 1
          receptor agonist 1
            lysergic acid diethylamide 0
paths to the root